Latest Alzheimer's disease News
It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?
The first drug shown to slow Alzheimer’s disease hit the U.S. market over a year ago, but sales have lagged, major hospital systems have taken months to start using it and some insurers have rejected coverage. Doctors also expect some patients will hesitate to take Leqembi due to...
FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer's drug
INDIANAPOLIS (AP) — Federal regulators put off a decision on whether to approve an Eli Lilly Alzheimer’s drug by making an unusual request to have outside advisers look at the treatment. Lilly had expected the Food and Drug Administration to decide on donanemab's approval by the...
Silent brain changes precede Alzheimer's. Researchers have new clues about which come first
WASHINGTON (AP) — Alzheimer’s quietly ravages the brain long before symptoms appear and now scientists have new clues about the dominolike sequence of those changes — a potential window to one day intervene. A large study in China tracked middle-aged and older adults for 20...
Biogen will stop selling its controversial Alzheimer's drug Aduhelm
Biogen will stop selling its Alzheimer’s treatment Aduhelm, a drug once seen as a potential blockbuster that stumbled after its launch a few years ago. The drugmaker also said Wednesday that it will end a study of the drug needed for full approval from the Food and Drug...
